Funded Startups in Rehovot
The largest disclosed round in Rehovot is Lusix’s $90M (2022-06-09), which dwarfs the next-largest disclosed amount at $35M (Equinom, 2022-12-12).
The largest disclosed round in Rehovot is Lusix’s $90M (2022-06-09), which dwarfs the next-largest disclosed amount at $35M (Equinom, 2022-12-12). Disclosed amounts also show a clear lower tail: the smallest disclosed is Kinoko-Tech’s $30K (2022-06-15), while multiple others cluster around the $20M level (Wi Charge $20M on 2025-05-15; Biomica $20M on 2022-12-21; Silentium $20M on 2021-06-15).
Most entries are tightly geography-consistent: all 32 records list Rehovot as the city. Temporally, the rounds span 2020-12-02 to 2026-07-20, with the most recent disclosed amount being eyesAtop’s $15M Seed on 2026-07-20. Sector-wise, biotech appears repeatedly (Collplant 2026-06-30 $3M; Raziel Therapeutics undisclosed on 2026-06-29; Evogene 2024-08-23 $6M; Biomica 2022-12-21 $20M; POCARED Diagnostics 2022-05-12 $23M), and “Series Unknown” shows up often (e.g., Collplant, Raziel Therapeutics, Aleph Farms, and others), reinforcing that classification is uneven across the dataset.
Most recent rounds
32 shownRelated listings
Frequently asked
What stands out in deal size, and how extreme is the top disclosed round?
Lusix’s $90M (2022-06-09) is the only disclosed amount at that level; the next-largest disclosed round is $35M (Equinom, 2022-12-12). The low end is also pronounced: Kinoko-Tech’s $30K (Grant, 2022-06-15) is the smallest disclosed amount in the list.
Are there clear temporal clusters among the most recent rounds shown?
Yes. Several disclosed rounds concentrate in 2024–2025, including Aleph Farms $29M (2025-03-25), Wi Charge $20M (2025-05-15), eyesAtop $15M (2026-07-20), and FreezeM $14M (2024-02-14). In contrast, the earliest disclosed entries start at least as far back as 2020-12-02 (SavorEat $13M).
Is Rehovot consistently represented, or do any records point to different city names?
City coverage is uniform: all 32 rows list Rehovot as the city appearing more than once. Examples include eyesAtop (2026-07-20, $15M) and SavorEat (2020-12-02, $13M), both explicitly tied to Rehovot.
Which sectors are over-represented versus single occurrences in this list?
Biotechnology is a repeat sector across multiple years and stages: Collplant (2026-06-30, $3M), Evogene (2024-08-23, $6M), Biomica (2022-12-21, $20M), and POCARED Diagnostics (2022-05-12, $23M). Other sectors like Food and Beverage also recur, but biotech is the clearest multi-entry concentration from the shown rows.
How often is the round classification missing, and does that affect interpretability of the mix?
“Series Unknown” appears frequently across different sectors and dates, including Collplant (2026-06-30, $3M), Raziel Therapeutics (2026-06-29, undisclosed), Maris Tech Ltd. (2026-03-06, $2M), and Aleph Farms (2025-03-25, $29M). That pattern is reinforced by additional non-standard labels such as “Grant” for Kinoko-Tech (2022-06-15, $30K) and “Debt Financing” for POCARED Diagnostics (2022-05-12, $23M).
Which entries are outliers by both sector and disclosed size?
Large-size outliers are separated from the rest by a wide gap: Lusix ($90M, Software; 2022-06-09) leads by a large margin over the next-largest disclosed $35M (Equinom, Agriculture and Farming; 2022-12-12). On the other end, the smallest disclosed amount is Kinoko-Tech’s $30K (Food and Beverage; Grant; 2022-06-15), far below the typical $1M–$20M disclosed range visible in entries such as Salvador Technologies ($1M, 2026-01-05) and several $20M rounds.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.